Fig 1.
NTG indicates normal tension glaucoma; IOP, intraocular pressure; OPP, ocular perfusion pressure; DTFC, dorzolamide/timolol fixed combination.
Table 1.
Baseline demographics and clinical characteristics of the study population.
VF = visual field; RNFL = retinal nerve fiber layer.
Fig 2.
Mean intraocular pressure during the circadian curve for the three crossover phases: at baseline, after dorzolamide/timolol, and after latanoprost.
Vertical bars indicate the 95% confidence interval of the estimates.
Table 2.
Intraocular pressure diurnal profiles of two groups.
DTFC = dorzolamide-timolol fixed combination
Fig 3.
Mean systolic and diastolic blood pressure (BP) during the circadian curve for the three crossover phases: at baseline, after dorzolamide/timolol, and after latanoprost.
Vertical bars indicate the 95% confidence interval of the estimates.
Fig 4.
Mean ocular perfusion pressure and diastolic ocular perfusion pressure during the circadian curve for the three crossover phases: at baseline, after dorzolamide/timolol, and after latanoprost.
Vertical bars indicate the 95% confidence interval of the estimates.
Table 3.
Systolic BP and diastolic BP diurnal profiles of two groups.
Table 4.
Heart rate diurnal profiles of two groups.
Table 5.
Ocular perfusion pressure diurnal profiles of two groups.
Table 6.
Diastolic ocular perfusion pressure diurnal profiles of two groups.
Table 7.
Number (%) of Patients with Ocular Treatment-Related Adverse Events.